Parallel Advisors, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$354
-92.9%
11
-96.4%
0.00%
Q4 2021$5,000
-92.4%
308
-86.9%
0.00%
-100.0%
Q3 2021$66,000
+1.5%
2,353
+7.4%
0.00%0.0%
Q2 2021$65,000
+550.0%
2,190
+471.8%
0.00%
+200.0%
Q3 2020$10,000
+11.1%
3830.0%0.00%0.0%
Q2 2020$9,000
+80.0%
3830.0%0.00%
Q1 2020$5,000
-16.7%
3830.0%0.00%
Q4 2019$6,000
+20.0%
3830.0%0.00%
Q3 2019$5,000
+150.0%
383
+150.3%
0.00%
Q2 2019$2,0001530.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders